Author

Mahdi Goudarzvand

Observed names: Goudarzvand, Mahdi, M Goudarzvand, M. Goudarzvand
ORCID: 0000-0002-4229-5148
Observed ORCID: 0000-0002-4229-5148
OpenAlex ID: A5034832140
2015 · Mohammad Hassan Naseri, Majid Mahdavi, et al. · Cancer Cell International · 213
2014 · Saeid Yazdi-Ravandi, Yasaman Razavi, et al. · Pharmacology Biochemistry and Behavior · 49
2016 · Sanaz Afraei, Gholamreza Azizi, et al. · Neural Regeneration Research · 38
2014 · Neda Rashidi-Ranjbar, Mahdi Goudarzvand, et al. · Frontiers in Human Neuroscience · 36
2023 · Ghazale Molaverdi, Zahra Kamal, et al. · eNeurologicalSci · 32
2015 · Gholamreza Azizi, Mahdi Goudarzvand, et al. · Immunopharmacology and Immunotoxicology · 31
2018 · Farahnaz Nikdoust, Elham Bolouri, et al. · Journal of Cardiovascular and Thoracic Research · 30
2016 · Mahdi Goudarzvand, Samira Choopani, et al. · PubMed Central · 28
2020 · Fatemeh Kiaee, Majid Zaki-Dizaji, et al. · Endocrine Metabolic & Immune Disorders - Drug Targets · 27
2016 · Ghorbangol Ashabi, Alireza Sarkaki, et al. · Canadian Journal of Physiology and Pharmacology · 24
2014 · Nazila Aazami, Gholamreza Salehi Jouzani, et al. · The Journal of General and Applied Microbiology · 22
2016 · Mahdi Goudarzvand, Samira Rasouli Koohi, et al. · PubMed Central · 21
2013 · Zohreh Khodaii, Mahboobeh Mehrabani Natanzi, et al. · International Journal of Enteric Pathogens · 19
2022 · Nasim Saeidi, Hadi Goudarzvand, et al. · Multiple Sclerosis and Related Disorders · 10
2018 · Abbas Azadmehr*, Mahdi Goudarzvand, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 6
2023 · Nasim Niki Saeidi, Arezou Dabiri, et al. · Journal of Biomedical Research & Environmental Sciences · 5
2020 · Hasan N. Ahmadabad, Allireza Abbaspour, et al. · Endocrine Metabolic & Immune Disorders - Drug Targets · 5
Works count: 48
Citation count: 1,249
H-index: 18
I10-index: 21
Year
Topic
Type